WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Xi says he enjoys Yugoslav films, songs when youngTaiwan's WHA participation must fall under oneNadhim Zahawi insists Tories were 'wrong to oust Boris Johnson': Former Chancellor hails exXi says he enjoys Yugoslav films, songs when youngTrump sees massive surge in the polls with surprise demographic: 'Truly historic'Acosta has 1 goal, 2 assists, Cincinnati beats St. Louis 3Oleksandr Usyk beats Tyson Fury to become undisputed heavyweight champJosé Ramírez homers, drives in 3 runs as AL CentralNorthern Ireland secretary Chris HeatonHeartbreak as Tyson Fury is defeated by Oleksandr Usyk in the fight of the century
1.8103s , 6573.8671875 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Stellar Series news portal